Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000934347) titled 'A Study in Adult Volunteers to Understand the Safety and Effects of a New Drug, PTC612 with Food Effect (Part2)' on July 29.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Crossover
Primary Sponsor: PTC Therapeutics, Inc.
Condition:
inflammatory diseases
inflammatory diseases
Inflammatory and Immune System - Other inflammatory or immune system disorders
Intervention:
Unique participants will be enrolled in each part and each cohort, part 2 of the study consists of two cohorts of eligible participants to eval...